Clinical Trial Update: A Study of the Efficacy and Safety of Topiramate in Obese, Type 2 Diabetic Patients Inadequately Controlled on Sulfonylurea Therapy [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating topiramate for obesity in adults with type 2 diabetes inadequately controlled on sulfonylurea therapy; the study has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Type 2 Diabetes Mellitus

Drugs mentioned

• Topiramate (Topiramate)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Obesity, Diabetes Mellitus, Type 2 | Phase 3 | Status: TERMINATED